Literature DB >> 16714395

Pathobiological characteristics of intestinal and diffuse-type gastric carcinoma in Japan: an immunostaining study on the tissue microarray.

Huachuan Zheng1, Hiroyuki Takahashi, Yoshihiro Murai, Zhengguo Cui, Kazuhiro Nomoto, Shigeharu Miwa, Koichi Tsuneyama, Yasuo Takano.   

Abstract

AIM: To investigate the pathobiological features of intestinal and diffuse-type gastric carcinomas in the Japanese population.
METHODS: The expression of fragile histine triad (FHIT), phosphatase and tensin homology deleted from human chromosome 10 (PTEN), caspase-3, Ki-67, mutant p53, matrix metalloproteinase (MMP)-2, MMP-9, and extracellular matrix metalloproteinase inducer (EMMPRIN) on tissue microarrays of gastric carcinomas by immunostaining was examined in comparison with the clinicopathological characteristics between intestinal and diffuse-type cases.
RESULTS: Intestinal-type carcinoma frequently occurred in old men, whereas the diffuse type comparatively occurred more in young women (p<0.05). The diffuse-type carcinoma was more inclined to invasion into muscularis propria, lymphatic invasion and lymph node metastasis, and belonged to higher International Union against Cancer (UICC) staging (p<0.05) compared with intestinal-type counterparts. Expression of FHIT, PTEN, Ki-67, caspase-3, mutant p53 and EMPPRIN was higher in intestinal-type carcinomas than in diffuse-type carcinomas (p<0.05). Kaplan-Meier analysis indicated that patients with intestinal-type carcinomas had a higher cumulative survival rate (p<0.05).
CONCLUSION: Intestinal-type gastric carcinomas with a more favourable prognosis frequently show high levels of proliferation and apoptosis, and always accompany strong expression of FHIT, PTEN and mutant p53 and EMMPRIN. EMMPRIN expression might underlie the molecular basis of liver metastasis and higher proliferation of intestinal-type gastric carcinomas in Japan. Lauren's classification thus proved pathologically relevant for the clinical treatment of gastric carcinomas.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16714395      PMCID: PMC1860577          DOI: 10.1136/jcp.2006.038778

Source DB:  PubMed          Journal:  J Clin Pathol        ISSN: 0021-9746            Impact factor:   3.411


  20 in total

1.  Improved 1-h rapid immunostaining method using intermittent microwave irradiation: practicability based on 5 years application in Toyama Medical and Pharmaceutical University Hospital.

Authors:  Tokimasa Kumada; Koichi Tsuneyama; Hideki Hatta; Shin Ishizawa; Yasuo Takano
Journal:  Mod Pathol       Date:  2004-09       Impact factor: 7.842

2.  Carcinoma of the stomach in incipient phase: its histogenesis and histological appearances.

Authors:  K Nakamura; H Sugano; K Takagi
Journal:  Gan       Date:  1968-06

Review 3.  FHIT as tumor suppressor: mechanisms and therapeutic opportunities.

Authors:  Yuri Pekarsky; Alexey Palamarchuk; Kay Huebner; Carlo M Croce
Journal:  Cancer Biol Ther       Date:  2002 May-Jun       Impact factor: 4.742

4.  Extent of spontaneous apoptosis in gastric cancer: relation to proliferative index, p53 expression, CD 34 expression and histopathological features.

Authors:  D Jesionek-Kupnicka; M Tenderenda; P Rutkowski
Journal:  J Exp Clin Cancer Res       Date:  2002-09

5.  Role of PTEN and MMP-7 expression in growth, invasion, metastasis and angiogenesis of gastric carcinoma.

Authors:  Hua-Chuan Zheng; Jin-Min Sun; Xiao-Han Li; Xue-Fei Yang; Yin-Chang Zhang; Yan Xin
Journal:  Pathol Int       Date:  2003-10       Impact factor: 2.534

6.  Expression of Fas ligand and caspase-3 contributes to formation of immune escape in gastric cancer.

Authors:  Hua-Chuan Zheng; Jin-Min Sun; Zheng-Li Wei; Xue-Fei Yang; Yin-Chang Zhang; Yan Xin
Journal:  World J Gastroenterol       Date:  2003-07       Impact factor: 5.742

Review 7.  The biological model of gastric carcinogenesis.

Authors:  Pelayo Correa
Journal:  IARC Sci Publ       Date:  2004

8.  Pathobiological behavior and molecular mechanism of signet ring cell carcinoma and mucinous adenocarcinoma of the stomach: a comparative study.

Authors:  Xue-Fei Yang; Lin Yang; Xiao-Yun Mao; Dong-Ying Wu; Su-Min Zhang; Yan Xin
Journal:  World J Gastroenterol       Date:  2004-03-01       Impact factor: 5.742

9.  A comparison of patterns of metastasis in gastric cancer by histologic type and age.

Authors:  Y Esaki; R Hirayama; K Hirokawa
Journal:  Cancer       Date:  1990-05-01       Impact factor: 6.860

10.  Emmprin promotes anchorage-independent growth in human mammary carcinoma cells by stimulating hyaluronan production.

Authors:  Erica A Marieb; Alexandra Zoltan-Jones; Rongsong Li; Suniti Misra; Shibnath Ghatak; Jian Cao; Stanley Zucker; Bryan P Toole
Journal:  Cancer Res       Date:  2004-02-15       Impact factor: 12.701

View more
  58 in total

1.  Metastatic lymph node ratio and Lauren classification are independent prognostic markers for survival rates of patients with gastric cancer.

Authors:  Huan Wang; Xiao-Ming Xing; Lei-Na Ma; Lian Liu; Jing Hao; Ling-Xin Feng; Zhuang Yu
Journal:  Oncol Lett       Date:  2018-04-13       Impact factor: 2.967

2.  Deregulation of the cell polarity protein Lethal giant larvae 2 (Lgl2) correlates with gastric cancer progression.

Authors:  Kyung Han Nam; Min A Kim; Gheeyoung Choe; Woo Ho Kim; Hye Seung Lee
Journal:  Gastric Cancer       Date:  2013-12-13       Impact factor: 7.370

3.  Early gastric cancer with a mixed-type Lauren classification is more aggressive and exhibits greater lymph node metastasis.

Authors:  Jeung Hui Pyo; Hyuk Lee; Byung-Hoon Min; Jun Haeng Lee; Min Gew Choi; Jun Ho Lee; Tae Sung Sohn; Jae Moon Bae; Kyoung-Mee Kim; Seungmin Yeon; Sin-Ho Jung; Jae J Kim; Sung Kim
Journal:  J Gastroenterol       Date:  2016-09-02       Impact factor: 7.527

4.  Aberrant Pim-3 expression is involved in gastric adenoma-adenocarcinoma sequence and cancer progression.

Authors:  Hua-Chuan Zheng; Koichi Tsuneyama; Hiroyuki Takahashi; Shigeharu Miwa; Toshiro Sugiyama; Boryana Konstantinova Popivanova; Chifumi Fujii; Kazuhiro Nomoto; Naofumi Mukaida; Yasuo Takano
Journal:  J Cancer Res Clin Oncol       Date:  2007-09-18       Impact factor: 4.553

5.  Individual having a parent with early-onset gastric cancer may need screening at younger age.

Authors:  Hee-Won Kwak; Il Ju Choi; Chan Gyoo Kim; Jong Yeul Lee; Soo-Jeong Cho; Bang Wool Eom; Hong Man Yoon; Jungnam Joo; Keun Won Ryu; Young-Woo Kim
Journal:  World J Gastroenterol       Date:  2015-04-21       Impact factor: 5.742

6.  Expression and clinical significance of focal adhesion kinase in the two distinct histological types, intestinal and diffuse, of human gastric adenocarcinoma.

Authors:  Constantinos T Giaginis; Stephanie Vgenopoulou; Gerasimos S Tsourouflis; Ekaterini N Politi; Gregorios P Kouraklis; Stamatios E Theocharis
Journal:  Pathol Oncol Res       Date:  2008-11-06       Impact factor: 3.201

7.  Increased WNT6 expression in tumor cells predicts unfavorable survival in esophageal squamous cell carcinoma patients.

Authors:  Lin Zhang; Gang Yuan; Yujing Fang; Miaozhen Qiu; Jianhua Lin; Jian Sun; Dajun Yang
Journal:  Int J Clin Exp Pathol       Date:  2015-09-01

8.  Beclin 1 expression is an independent prognostic factor for gastric carcinomas.

Authors:  Miao Yu; Wen-feng Gou; Shuang Zhao; Li-jun Xiao; Xiao-yun Mao; Ya-nan Xing; Hiroyuki Takahashi; Yasuo Takano; Hua-chuan Zheng
Journal:  Tumour Biol       Date:  2013-01-19

9.  Oncogenic pathway combinations predict clinical prognosis in gastric cancer.

Authors:  Chia Huey Ooi; Tatiana Ivanova; Jeanie Wu; Minghui Lee; Iain Beehuat Tan; Jiong Tao; Lindsay Ward; Jun Hao Koo; Veena Gopalakrishnan; Yansong Zhu; Lai Ling Cheng; Julian Lee; Sun Young Rha; Hyun Cheol Chung; Kumaresan Ganesan; Jimmy So; Khee Chee Soo; Dennis Lim; Weng Hoong Chan; Wai Keong Wong; David Bowtell; Khay Guan Yeoh; Heike Grabsch; Alex Boussioutas; Patrick Tan
Journal:  PLoS Genet       Date:  2009-10-02       Impact factor: 5.917

10.  The role of mTOR and phospho-p70S6K in pathogenesis and progression of gastric carcinomas: an immunohistochemical study on tissue microarray.

Authors:  Li Xiao; Yi C Wang; Wu S Li; Yan Du
Journal:  J Exp Clin Cancer Res       Date:  2009-12-13
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.